Results indicated that the Col1α2 expression was higher in patient with fibrolamellar carcinoma or hepatocholangiocarcinoma (Figure 3B), and patients with later stages of HCC also exhibited increased Col1α2 levels, indicating its potential role in cancer progression (Figure 3C). Here, COL1A2 is linked to hepatocellular carcinoma.